Evidence map›Paper›PMID 42900669›Full record

ArticlePLoS pathogens2026

Selective persistence of HIV-1-infected T cell clones can occur through immune reprogramming driven by defective, transcriptionally active proviruses.

Martin V Hamann, Lisa Brauckmann, Christoph Schwarz, Michael Spohn, Ramon Stoeck, Sabrina M Leddy, Julie Frouard, Maisha Adiba, Riekje Winzer, Fabian Hausmann and 8 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Martin V HamannResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.
Lisa BrauckmannResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.
Christoph SchwarzResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.
Michael SpohnBioinformatics Core, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ramon StoeckResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.
Sabrina M LeddyResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.
Julie FrouardGladstone Institutes, University of California San Francisco (UCSF), San Francisco, California, United States of America.
Maisha AdibaResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.
Riekje WinzerInstitute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Fabian HausmannResearch Department Integrative Virology, Leibniz Institute of Virology, Hamburg, Germany.ORCID https://orcid.org/0000-0001-6110-5824
Sanamjeet VirdiResearch Department Virus Genomics, Leibniz Institute of Virology, Hamburg, Germany.
Adam GrundhoffResearch Department Virus Genomics, Leibniz Institute of Virology, Hamburg, Germany.
Cedric FeschotteDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, New York, United States of America.
Daniel SauterInstitute for Medical Virology and Epidemiology of Viral Diseases, University Hospital Tübingen, Tübingen, Germany.ORCID https://orcid.org/0000-0001-7665-0040
Frauke MueckschDepartment of Infectious Diseases, Virology, Heidelberg University, Heidelberg, Germany.
Nadia R RoanGladstone Institutes, University of California San Francisco (UCSF), San Francisco, California, United States of America.
Eva TolosaInstitute of Immunology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ulrike C LangeResearch Unit Genomics of Retroviral Infections, Leibniz Institute of Virology, Hamburg, Germany.ORCID https://orcid.org/0009-0002-5274-3108

Funding

HOPE - HIV Obstruction by Programmed EpigeneticsUM1AI164559 · NIAID · J. DAVID GLADSTONE INSTITUTES · PI Lishomwa C Ndhlovu, Melanie Maria Ott · 2021 to 2026
$32.2M
NIAID NIH HHS UM1 AI164559
6 · The paper itself

Abstract

People living with HIV (PLWH) on antiretroviral therapy (ART) accumulate primarily defective proviral sequences in genomes of often clonally expanded CD4 + HIV-1 target cells. The majority of viral-derived DNA is transcriptionally active and preferentially found at distinct genomic loci suggesting a selective process driven by integration site-specific crosstalk between viral and host sequences. Focusing on one of the most prominent selected integration loci, the BTB Domain and CNC Homolog 2 (BACH2) gene, we here show mechanistic insights how CD4 + T cells are functionally reprogrammed via exaptation of provirus-derived regulatory sequences during long-term ART. Using a cellular model of BACH2-integrated proviruses, we find that proviral transcription drives aberrant BACH2 protein levels that escape autoregulatory feedback and impose BACH2-dependent transcriptomic changes. By mimicking these changes in primary CD4 + T lymphocytes, we observe that BACH2 drives reprogramming of cells toward a proliferative, precursor memory-like type. These reprogrammed CD4 + T cells possess traits of immune evasion and cellular survival that are signatures of persistent HIV reservoir cells in PLWH. Inhibition of provirus transcriptional activity can mitigate exaptation, suggesting a strategy to offset HIV-driven differentiation and expansion of CD4 + T cells. Finally, our data suggest that provirus exaptation at a second prominently selected proviral integration gene, the Signal Transducer And Activator of Transcription 5B (STAT5B) gene, drives a contrary, effector-like T cell fate, suggesting a multifaceted impact of exaptation on immune homeostasis. Overall, our data suggest that transcriptionally active proviruses, even if structurally defective, modulate target cells through insertional activation of integration genes, a process which we postulate to contribute to the complex immune modulation and dysregulation experienced by ART-suppressed PLWH.

Indexed as

CD4-Positive T-LymphocytesHIV-1HIV InfectionsProvirusesBasic-Leucine Zipper Transcription FactorsHumansTranscription, GeneticVirus IntegrationBACH2 protein, humanBasic-Leucine Zipper Transcription Factors

Identifiers

PMID42900669
PMCPMC13682663

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.